Showing results for Pediatrics
-
IU scientists develop new bone marrow imaging technique
Study could impact treatment of cancer, autoimmune disease and musculoskeletal disorders.
Apr 24, 2025 -
Physician in new School of Medicine leadership role will serve as a scientific lead for IU LAB
D. Wade Clapp has been named the inaugural senior associate dean for entrepreneurial research and commercialization for the IU School of Medicine.
-
Form of vitamin E linked to severe allergy prevention early in life
A new study in mice by researchers at the Indiana University School of Medicine suggests that alpha-tocopherol, a form of vitamin E, may help prevent ...
Feb 25, 2025 -
IU School of Medicine faculty elected 2025 members of American Society for Clinical Investigation
Three Indiana University School of Medicine faculty have been recognized as 2025 members of the American Society for Clinical Investigation.
Feb 18, 2025 -
High uric acid levels linked to deadly outcomes in children with severe malaria
IU School of Medicine researchers and their collaborators have uncovered a connection between elevated uric acid levels and life-threatening outcomes in children with severe malaria. ...
Jan 27, 2025 -
$3.2 million grant to advance research on benefits of low oxygen in blood stem cell treatments
IU School of Medicine scientists have been awarded a new NIH grant for research aimed at enhancing therapies like bone marrow transplants, which are critical ...
Jan 22, 2025 -
$1.1 million grant to help researchers improve Type 1 diabetes screening in Indiana
IU School of Medicine diabetes researchers received a $1.1 million grant to advance screening strategies for the early detection of Type 1 diabetes.
Jan 14, 2025 -
Asthma more prevalent among children with primary ciliary dyskinesia
Researchers have uncovered compelling evidence that children with primary ciliary dyskinesia are significantly more likely than children without PCD to have asthma.
Dec 12, 2024 -
Study uncovers first evidence of resistance to standard malaria treatment in African children with severe malaria
Researchers have uncovered evidence of partial resistance to artemisinin derivatives — the primary treatment for malaria — in young children with severe malaria.
Nov 14, 2024 -
Gut microbiome differences in children linked to febrile malaria development
New research emphasizes the gut microbiome's significant role in febrile malaria development.
Nov 06, 2024